Have a personal or library account? Click to login
A review: antibodies with high-titer, low-avidity characteristics Cover

A review: antibodies with high-titer, low-avidity characteristics

By: S. Rolih  
Paid access
|Dec 2020

References

  1. Giles CM, Huth MC, Wilson TE, et al. Three examples of a new antibody, anti-Csa, which reacts with 98% of all red cell samples. Vox Sang 1965;10:405–15.
  2. Giles CM. A genetical and serological study of two newly discovered blood group antibodies. PhD thesis, University of London, 1968.
  3. Molthan L, Crawford MN, Giles CM, et al. A new antibody, anti-Yka (York) and its relationship to anti-Csa (Cost-Stirling) (abstract). Transfusion 1969;9:281.
  4. Molthan L, Giles CM. A new antigen, Yka (York), and its relationship to Csa (Cost). Vox Sang 1975;29:145–53.10.1111/j.1423-0410.1975.tb00488.x1146279
  5. Molthan L, Parpadis DJ. Anti-Csb: the finding of the antibody antithetical to anti-Csa. Med Lab Sci 1987;44:94–6.
  6. Helgeson M, Swanson J, Polesky H. Knops-Helgeson (Kna), a high frequency erythrocyte antigen. Transfusion 1970;10:137–8.10.1111/j.1537-2995.1970.tb00720.x4192883
  7. Molthan L, Moulds J. A new antibody anti-McCa (McCoy) and its relationship to anti-Kna (Knops) (abstract). Transfusion 1975;15:522.
  8. Molthan L. The status of the McCoy/Knops antigens. Med Lab Sci 1983;40:59–63.
  9. Molthan L, Moulds J. A new antigen, McCa (McCoy), and its relationship to Kna (Knops). Transfusion 1978;18:566–8.10.1046/j.1537-2995.1978.18579036386.x705863
  10. Molthan L. Anti-York (Yka) and other HTLA antibodies (Csa, McCa, Kna) revisited. Transfusion 1978;18:622.
  11. Mallan MT, Grimm W, Hindley L, et al. The Hall serum: detecting Knb, the antithetical allele to Kna (abstract). Transfusion 1980;20:630.
  12. Molthan L. Expansion of the York, Cost, McCoy, Knops blood group system: the new McCoy antigens McCc and McCd. Med Lab Sci 1983;40:113–21.
  13. Lacey P, Laird-Fryer B, Block U, et al. A new high incidence blood group factor, Sla and its hypothetical allele (abstract). Transfusion 1980;20:632.
  14. Sabo B, Moulds JJ, McCreary J. Anti-JMH: another high titer-low avidity antibody against a high frequency antigen (abstract). Transfusion 1978;18:387.
  15. Kollmar MB, South SF, Tregellas WM. Evidence of genetic mechanism for the production of the JMH negative phenotype (abstract). Transfusion 1981;21:612.
  16. Daniels GL. Blood group antigens of high frequency: A serological and genetical study. Doctoral thesis, University College, London, 1980, p 435.
  17. Harris JP, Tegoli J, Swanson J, et al. A nebulous antibody responsible for crossmatching difficulties (Chido). Vox Sang 1967;12:140–2.10.1111/j.1423-0410.1967.tb03078.x6016836
  18. Middleton J, Crookston MC. Chido substance in plasma. Vox Sang 1972;23:256–61.10.1111/j.1423-0410.1972.tb03459.x5081019
  19. Longster G, Giles CM. A new antibody specificity, anti-Rga, reacting with a red cell and serum antigen. Vox Sang 1976;30:175–7.10.1111/j.1423-0410.1976.tb02810.x1251581
  20. O’Neill G, Yang SY, Tegoli J, et al. Chido and Rodgers are distinct antigenic components of human complement C4. Nature 1978;273:668–70.10.1038/273668a078453
  21. Beattie KM, Castillo S. A case report of a hemolytic transfusion reaction caused by anti-Holley. Transfusion 1975;15:476–80.
  22. Hsu TCS, Jagathambal K, Sabo BH, et al. Anti-Holley (Hy): Characterization of another example Transfusion 1975;15:604-710.1046/j.1537-2995.1975.15676082238.x1198690
  23. Moulds JJ, Polesky HF, Reid M, et al. Observations on the Gya and Hy antigens and the antibodies that define them. Transfusion 1975;15:270–4.10.1046/j.1537-2995.1975.15375160364.x1129835
  24. Ellisor SS, Reid ME, Avoy DR, et al. Transient anti-Gy3 in an untransfused man. Serologic characteristics and red cell survival study. Transfusion 1982;22:166–8.10.1046/j.1537-2995.1982.22282177131.x7071923
  25. Fischer JR, Dilbeck M, Rolih SD, et al. Apparent successful transfusion of incompatible red cells to a patient with anti-Gya (abstract). The 33rd Annual Meeting, Southeastern Blood Banks, 1983.
  26. Massaquoi JM. Two further examples of anti-Gya. Transfusion 1975;15:150–1.10.1046/j.1537-2995.1975.15275122810.x1118881
  27. Vengelen-Tyler V. Nonneutralizable HTLA antibodies and the antigens they define. In: Rolih SD, ed. High-titer, low-avidity antibodies: recognition and resolution. Washington, DC: American Association of Blood Banks, 1980:21–32.
  28. Moulds MK. Special serologic technics useful in resolving high-titer, low-avidity antibodies. In: Rolih SD, ed. High-titer, low-avidity antibodies: recognition and resolution. Washington, DC: American Association of Blood Banks, 1980:33–43.
  29. Issitt PD: Applied blood group serology, 3rd ed. Miami: Montgomery Scientific, 1985:430-3.
  30. Moulds JJ, Levene C, Zimmerman S. Serological evidence for heterogeneity among antibodies compatible with JMH-negative red cells (abstract). Proceedings of the 19th Congress International Society on Blood Transfusion, Basel:1982; Karger:287.
  31. Daniels GL. Knowles RW Monoclonal antibody to the high frequency red cell antigen JMH. J Immunogenet 1982;9:57–9.10.1111/j.1744-313X.1982.tb00783.x
  32. Daniels GL, Knowles RW. Further analysis of the monoclonal antibody H8 demonstrating a JMH-related specificity. J Immunogenet 1983;10:257–8.10.1111/j.1744-313X.1983.tb00802.x
  33. Giles CM. An update on Rodgers and Chido, the antigenic determinants of C4. Immunohematology 1989;5:1–6.10.21307/immunohematology-2019-1057
  34. O’Neill GJ, Yang SY, Dupont B. Two HLA-linked loci controlling the fourth component of human complement. Proc Natl Acad Sci USA 1978;75:5165–8.10.1073/pnas.75.10.5165336285368809
  35. Middleton J, Crookston MC, Falk JA, et al. Linkage of Chido and HLA. Tissue Antigens 1975;4:366-7310.1111/j.1399-0039.1974.tb00262.x4414486
  36. Giles CM, Gedde-Dahl T, Robson ED, et al. Rga (Rodgers) and the HLA region: linkage and association. Tissue Antigens 1976;8:143–9.10.1111/j.1399-0039.1976.tb00578.x
  37. Roos MH, Mollenhauer E, Demant P, et al. A molecular basis for the two locus model of human complement component C4. Nature 1982;298:854–6.10.1038/298854a06180321
  38. Tilley CA, Romans DG, Crookston MC. Localisation of Chido and Rodgers determinants to the C4d fragment of human C4. Nature 1978;276:713–5.10.1038/276713a083538
  39. Rittner C, Giles CM, Roos MH, et al. Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes. Immunogenetics 1984;19:321–33.10.1007/BF003454056201442
  40. Roos MH, Giles CM, Demant P, et al. Rodgers (Rg) and Chido (Ch) determinants of human C4: characterization of two C4B5 subtypes, one of which contains Rg and Ch determinants. J Immunol 1984;133:2634–40.10.4049/jimmunol.133.5.2634
  41. Humphrey J, Stout TD, Middleton J, et al. The identification of Chido-negative donors by plasma-inhibition test. In: abstracts of volunteer papers, American Association of Blood Banks 25th Annual Meeting, 13th International Congress of the International Society of Blood Transfusion. Washington, DC 1972:52.
  42. Giles CM. “Partial inhibition” of anti-Rg and anti-Ch reagents. I. Assessment for Rg/Ch typing by inhibition. Vox Sang 1985;48:160–6.
  43. Nordhagen R, Olaisen B, Teisbeŗg P, et al. Association between the electrophoretically determined C4A haplotype product and partial inhibition of anti-Cha. J Immunogenet 1980;7:301–6.10.1111/j.1744-313X.1980.tb00723.x
  44. Nordhagen R, Olaisen B, Teisbeŗg P, et al. C4 haplotype products ;ind partial inhibition of anti-Rodgers sera. J Immunogenet 1981;8:485-91.10.1111/j.1744-313X.1981.tb00957.x
  45. Giles CM. A new genetic variant for Chido. Vox Sang 1984;46:149–56.10.1111/j.1423-0410.1984.tb00067.x
  46. Giles CM. “Partial inhibition” of anti-Rg and anti-Ch reagents. II. Demonstration of separable antibodies for different determinants. Vox Sang 1985;48:167–73.
  47. Giles CM. Three Chido determinants detected on the B5Rg allotype of human C4; their expression in Ch-typed donors and families. Hum Immunol 1985;18:111–22.10.1016/0198-8859(87)90009-7
  48. Yu CY, Belt KT, Giles CM, et al. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. Eur Mol Biol Org J 1986; 5:2873–81.10.1002/j.1460-2075.1986.tb04582.x11672372431902
  49. Giles CM, Hoffman M, Moulds M, et al. Allo-anti-Chido in a Ch-positive patient. Vox Sang 1987;52:129–33.10.1111/j.1423-0410.1987.tb03008.x3604158
  50. Clark MJ, Poole J, Barnes RM, et al. Study of the Gregory blood group in an English family. Vox Sang 1975;29:301-510.1111/j.1423-0410.1975.tb00511.x1146282
  51. Reid ME, Ellisor SS, Sabo B. Absorption of anti-Hy from one of four Gy(a-) human red blood cell samples. Transfusion 1982;22:528–9.10.1046/j.1537-2995.1982.22683068619.x7147332
  52. Laird-Fryer B, Moulds MK, Moulds JJ, et al. Subdivision of Gya-Hy phenotypes (abstract). Transfusion 1981;21:633.
  53. Weaver T, Kavitsky D, Carty L, et al. An association between the Joa and Hy phenotypes (abstract). Transfusion 1984;24:426.
  54. Brown D. Reactivity of anti-Joa with Hy-red cells (abstract). Transfusion 1985;25:462.
  55. Tilley CA, Crookston MC, Haddad SA, et al. Red blood cell survival studied in patients with anti-Ch3, anti-Yk3, anti-Ge, and anti-Vel. Transfusion 1977;17;169–76.10.1046/j.1537-2995.1977.17277151924.x850935
  56. Shore GM, Steane EA. Survival of incompatible red cells in a patient with anti-Csa and three other patients with antibodies to high-frequency red cell antigens (abstract). Transfusion 1978;18:387.
  57. Valko DA, Silberstein EB, Greenwalt TJ, et al. Normal survival of in vitro reactive red cells in one patient with anti-McCa and one with anti-Csa (abstract). Transfusion 1981;21:603.
  58. Grove W, Peters B, Ellisor SS. Normal 51Cr red cell survival of York (Yka) positive blood in a patient with anti-Yka (abstract). Transfusion 1981;21:607.
  59. Ryden SE. Successful transfusion of a patient with anti-Yka (letter). Transfusion 1981;21:130–1.10.1111/j.1537-2995.1981.tb05678.x
  60. Wells RF, Korn G, Halfleigh B, et al. Characterization of three new apparently related high frequency antigens. Transfusion 1976;16:427–33.10.1046/j.1537-2995.1976.16577039297.x982534
  61. Viggiano E, Ballas SK. Erythrocyte survival studies of “Kna/McCa” incompatible blood in a patient with anti-“Kna/McCa” (abstract). Transfusion 1981;21:603.
  62. Harpool DR. Anti-Sla: lack of effect on transfused Sl(a-) red cells (letter). Transfusion 1983;23:402.10.1046/j.1537-2995.1983.23584018723.x6623609
  63. Tregellas WM, Pierce SR, Hardman JT, et al. Anti-JMH: IgG subclass composition and clinical significance. Transfusion 1980;20:628.
  64. Whitsett CF, Moulds M, Pierce JA, et al. Anti-JMH identified in serum and in eluate from red cells of a JMH-negative man. Transfusion 1983;23:344–5.10.1046/j.1537-2995.1983.23483276874.x6410552
  65. Moore HC, Issitt PD, Pavone BG. Successful transfusion of Chido positive blood to two patients with anti-Chido. Transfusion 1975;15:266–9.10.1046/j.1537-2995.1975.15375160363.x1129834
  66. Silvergleid AJ, Wells RF, Hafleigh EB, et al. Compatibility testing using 51Chromium-labeled red blood cells in crossmatch positive patients. Transfusion 1978;18:8–14.10.1046/j.1537-2995.1978.18178118571.x625785
  67. Nordhagen R, Alas M. Survival studies of 51Cr Ch(a+) red blood cells in a patient with massive transfusion of incompatible blood. Vox Sang 1979;37:179–81.10.1111/j.1423-0410.1979.tb02288.x494587
  68. Schanfield MS, Steven JO, Bauman D. The detection of clinically insignificant erythrocyte antibodies using human mononuclear phagocyte assay. Transfusion 1981;21:571–6.10.1046/j.1537-2995.1981.21582040822.x6794195
  69. Strohm PL, Molthan L. Successful transfusion results using Rg(+) blood in four patients with anti-Rga. Vox Sang 1983;45:48–52.
  70. Moulds JJ, Moulds MK. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide (letter). Transfusion 1983;23:274–5.10.1046/j.1537-2995.1983.23383224921.x6679393
  71. Marsh WL, Johnson CL, Meuller KA. AET-treated cells (letter). Transfusion 1983;23:275.10.1111/j.1537-2995.1983.tb02549.x
  72. Levene C, Harel N. 2-aminoethylisothiouronium bromide-treated red cells and the Cartwright (Yta) antigen (letter). Transfusion 1984;24:541.10.1046/j.1537-2995.1984.24685066825.x6506190
  73. Advani H, Zamor J, Judd WJ, et al. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide. Br J Haematol 1982;51:107–15.10.1111/j.1365-2141.1982.tb07295.x7073987
  74. Toy EM. Inactivation of high-incidence antigens on red cells by dithiothreitol. Immunohematology 1986;2:57-9.
  75. Eckrich RJ. Inactivation of Holley (Hy) and Gregory (Gy) antigens by dithiothreitol (DTT). Immunohematology 1988;4:12–3.10.21307/immunohematology-2019-1087
  76. Branch DR, Muench HA, Sy Siok, et al. Disulphide bonds are a requirement for Kell and Cartwright (Yra) blood group antigen activity. Br J Haematol 1983;54:573–8.10.1111/j.1365-2141.1983.tb02136.x6871108
  77. Rolih SD, Fisher E, Young R. Capture-R panel studies using unmodified and chemically modified red cells. Immuncor-respondence 1989;3:1–6.
  78. Gorman M, Gladden J. A case report: use of ZZAP reagents in the investigation of warm autoimmune hemolytic anemia. Immunohematology 1988;4:38–40.10.21307/immunohematology-2019-1098
  79. Green M, Lloyd L, Popovsky M, Gorman M. The effects of dithiothreitol on Dombrock system antigens (abstract). Transfusion 1989;29S:16S.
  80. Nordhagen R, Heier Larsen AM, Beckers D. Chido, Rodgers and C4. In vivo and in vitro coating of red blood cells, grouping and antibody detection. Vox Sang 1979;37:170–8.10.1111/j.1423-0410.1979.tb02287.x91269
  81. Judd WJ, Kraemer K, Moulds JJ. The rapid identification of Chido and Rodgers antibodies using C4d-coated red blood cells. Transfusion 1981;21:189–92.10.1046/j.1537-2995.1981.21281178155.x7222201
  82. Ellisor SS, Shoemaker M, Reid ME. Autoabsorption of anti-Chido using C4-coated red cells. Transfusion 1982;22:243–5.10.1046/j.1537-2995.1982.22382224951.x7046160
  83. Daniels GL, Shaw MA, Lomas CG et al. The effect of In(Lu) on some high-frequency antigens. Transfusion 1986;26:171–2.10.1046/j.1537-2995.1986.26286152909.x3952792
DOI: https://doi.org/10.21307/immunohematology-2019-1042 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 59 - 67
Published on: Dec 20, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 S. Rolih, published by American National Red Cross
This work is licensed under the Creative Commons License.